AI Signal & Stock Analysis · Very Strong ↑
As of Nov 9 2026, 8:45 AM, AkshayaAI's signal for SYRE is Very Strong ↑; the stock is at $108.77 (+4.73% today); neutral (RSI 69); technical trend is down-trend.
Data as of Nov 9 2026, 8:45 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal (Strength) | Very Strong ↑ |
|---|---|
| Price | $108.77 |
| Change today | +4.73% |
| RSI (14) | 69.11 |
| Relative volume | 0.67 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $10.3B |
| Forward P/E | 0.00 |
| 52-week high | -1.7% away |
| 52-week low | +412.3% above |
| Technical trend | Down-trend (since 2026-08-26) |
| News sentiment | — |
| Sector | Healthcare-Biotech |
| Next earnings | 11/3/2026 4:30:00 PM |
As of Nov 9 2026, 8:45 AM, AkshayaAI assigns SYRE (Spyre Therapeutics Inc) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
SYRE's RSI is neutral (RSI 69). A reading above 70 is typically considered overbought and below 30 oversold.
SYRE is trading about 2% below its 52-week high and 412% above its 52-week low as of Nov 9 2026, 8:45 AM.
SYRE's next earnings date is 11/3/2026 4:30:00 PM.
SYRE is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for SYRE — not personalised investment advice. Always do your own research.
VRTX · REGN · ARGX · ONC · RVMD · RPRX
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 9 2026, 8:45 AM and may not reflect real-time prices. Always do your own research. How these signals work →